# Trending Content OS — Daily Run
**Date:** 2026-10-13 | **Niche:** Health & Wellness

---

## 1. Preflight Summary

```yaml
preflight_status:
  all_sections_present: true
  missing_sections: []
  site_niche_set: true
  target_audience_set: true
  site_url_set: false
  serpapi_connected: true
  google_trends_available: true
  google_trends_tool: "serpapi_prefetch"
  active_tools: [serpapi_news, serpapi_trends, google_news_radar]
  inactive_tools: [reddit_api, social_search, content_database]
  can_run_signal_listener: true
  notes: "site_url not configured — self-check skipped; competitor-list fallback (configs/competitor_list.yaml) used for duplicate/SERP-gap context. Recurring-theme check against last 7 days of coverage: measles outbreak (2 mentions), FDA recalls (3+ mentions), World Mental Health Day/WHO mental health (4 mentions), AI-in-clinical-care (3 mentions) all flagged recurring — new coverage of these themes rejected or required a materially new development."
next_action: run_signal_listener
```

---

## 2. Google News Radar Coverage Summary

144 unique headlines clustered into 8 topic groups:

| Cluster | Disposition | Reasoning |
|---|---|---|
| **FDA recalls** (acetaminophen, baby sleep aid, pre-workout, supplement powder, smoked fish, Salmonella sprouts) | **Retained (update)** | Amazon acetaminophen recall ([USA Today](https://www.usatoday.com), [MedShadow](https://medshadow.org/drug-updates-recalls/fda-recalls-and-warnings/amazon-acetaminophen-millions-of-eye-drops-compounded-glutathione/)) is real-time trending with a confirmed news driver. Gatorade/eye drops/BP-med recalls already covered 10/06–10/08 → existing. Bundled new recalls into one "recall wave" update rather than 5 thin standalones. |
| **Medical study / clinical trial (AI-in-healthcare)** ([Lancet AMIE](https://blog.google/innovation-and-ai/technology/health/amie-clinical-study-lancet/), [NYT AI urgent care](https://www.nytimes.com/2026/10/08/technology/ai-chatbots-urgent-care.html), [BIDMC](https://bidmc.org/news-stories/all-news-stories/news/2026/10/bidmc-research-shows-safety-quality-of-ai-in-primary-care)) | **Rejected — existing** | Covered 10/09 (Lancet/AMIE) and 10/09 (NYT urgent-care trial). BIDMC piece is the same cluster, no new angle. |
| **Clinical trial cluster — therapeutics/diversity** ([USC psilocybin](https://keck.usc.edu/news/usc-launches-clinical-trial-of-psilocybin-and-mindfulness-meditation-for-depression/) existing; [Clinical Trials Arena women's health](https://www.clinicaltrialsarena.com/features/womens-health-landscape-shifting-systemic-hurdles-remain-2/), [Penn LDI diversity](https://ldi.upenn.edu/our-work/research-updates/what-would-it-take-to-make-clinical-trials-more-diverse/)) | **Split** | USC psilocybin = existing (10/11). Women's-health/diversity-in-trials analysis is a new, uncovered angle → retained, P3. |
| **Weight-loss drug news** — retatrutide ([SciTechDaily](https://www.scitechdaily.com)) | **Retained — new** | Not previously covered (Wegovy/Zepbound mechanism piece 10/11 was a different drug class story); Google Trends weight-loss interest up +16 7-day delta. |
| **Infectious disease / public health** — West Nile virus NC deaths ([WRAL](https://www.wral.com)) | **Retained — new** | Real-time Trending Now entry with confirmed fatality report; distinct from measles-outbreak cluster already covered 10/06 & 10/10. |
| **Mental health / WHO / World Mental Health Day** ([WHO](https://www.who.int/news/item/09-10-2026-who-urges-shift-from-institutional-to-community-based-mental-health-care), [EU Commission](https://commission.europa.eu/news-and-media/news/world-mental-health-day-lets-talk-and-listen-2026-10-10_en), Notre Dame parenting study) | **Rejected / Monitored** | WHO + World Mental Health Day = existing (10/07, 10/10). Notre Dame parenting/joy study is single-source, no corroboration, trend score below threshold → Monitor (P5), recheck in 7 days. |
| **Wellness-culture lifestyle pieces** (NYT polyester video, "wellness darties," Harvard wellness-culture op-ed, campus wellness fairs) | **Rejected** | No evidence-based health angle; falls outside allowed categories (cultural/lifestyle fluff, closer to excluded "alternative medicine/trend" territory). |
| **Political/healthcare-policy & local/niche** (KFF midterm poll, NYT Patty Murray op-ed, NC treasurer/Atrium story, NPR LA medical debt, Virginia shellfish closure, Google Fitbit product update, Rutgers opioid-ban research piece, UC Cincinnati grant announcement, Dell Med trial-standardization partnership, XORTX gout PR) | **Rejected** | Pure political opinion, local/narrow scope, consumer-tech product news, or process/funding announcements with no findings — fails category or audience-value bar. |

---

## 3. Signal Summary

```yaml
signal_summary:
  run_started_at: "2026-10-13T13:00:00Z"
  run_completed_at: "2026-10-13T13:45:00Z"
  total_signals_reviewed: 173
  total_signals_retained: 4
  total_rejected: 169
  google_trends_available: true
  search_velocity_source: "google_trends"
  rejection_breakdown:
    off_category: 48
    brand_safety: 3
    duplicate: 88
    weak_signal: 28
    unverified_claim: 0
    other: 2
  highest_priority_topic: "West Nile virus North Carolina deaths / Amazon acetaminophen recall (tied P1)"
  strongest_signal_source: "Google Trends Trending Now + Google News Radar convergence"
  tools_unavailable: [reddit_api, social_search, content_database]
  notes: "site_url not configured — self-check skipped; competitor-list fallback used. Talarico 'mental health' trending term excluded on brand-safety grounds (political figure, no evidence-based health angle despite high search velocity). Three recurring themes from the last 7 days (recalls, mental-health/WHO, AI-in-clinical-care) were deliberately not re-covered unless a new development justified an update."
```

---

## 4. Skill 02b — Health Claim Verification Gate Routing Summary

| Topic | Triggered | Risk Type | Result | Notes |
|---|---|---|---|---|
| Amazon acetaminophen recall | Yes | recall | **Pass (medium cap)** | Breaking-recall exception applied — 2 named outlets (USA Today, MedShadow) + implied FDA.gov recall listing; no direct FDA notice retrieved this session. Confidence capped at Medium until verified. |
| Retatrutide trial results | Yes | drug_or_treatment_claim / clinical_trial | **Pass** | SciTechDaily traces to underlying trial data; headline framing ("stunning results") is mild overstatement, not mechanism/scale distortion → passes with note to lead with actual trial language. |
| West Nile virus NC | No | n/a | **Not applicable** | Outbreak/fatality report, not a drug/study/supplement/recall/dosage claim — routed through standard Skill 06 validation instead. |
| Clinical trial diversity / women's health | No | n/a | **Not applicable** | Evaluative/analysis piece, not a specific verifiable health claim. |
| Notre Dame parenting study / UTSW protein study | Yes (would trigger) | study_or_research | **Monitor (did not reach gate — cut at Skill 04 for thin signal)** | Single-source, no corroboration; held for recheck rather than scored. |

---

## 5. Final Editorial Priority Board

| Priority | Topic | Trend | Opp. | Discover | Urgency | Confidence | Timing |
|---|---|---|---|---|---|---|---|
| **P1** | Amazon acetaminophen recall (Aurobindo Pharma) — FDA recall wave update | 78 | 64 | 4 | now | medium | immediate |
| **P1** | West Nile virus — North Carolina fatalities | 80 | 68 | 4 | now | medium | immediate |
| **P2** | Retatrutide: "beyond Ozempic" weight-loss trial results | 76 | 72 | 4 | today | medium | short_term |
| **P3** | Clinical trial diversity & the women's-health data gap | 52 | 64 | 3 | this_week | medium | scheduled |

```yaml
summary:
  total_topics: 4
  high_priority_count: 2
  immediate_actions: "Publish West Nile virus explainer and Amazon acetaminophen recall update within 24h; verify primary FDA notice before naming specific lot numbers."
```

---

## 6. Editorial Briefs

### P1 — Amazon Acetaminophen Recall (FDA Recall Wave Update)

```yaml
brief:
  primary_headline: "Amazon-Sold Acetaminophen Recalled — Here's What to Know About the Growing 2026 FDA Recall Wave"
  alternate_headlines:
    - "Acetaminophen Sold on Amazon Recalled by Aurobindo Pharma — What Shoppers Should Do"
    - "Another FDA Recall: Why Over-the-Counter Pain Relievers Keep Getting Pulled in 2026"
  topic: "Amazon acetaminophen recall (Aurobindo Pharma) — part of expanding FDA recall pattern"
  primary_entity: "Aurobindo Pharma acetaminophen recall"
  search_intent: "informational + evaluative (is my bottle affected / why do recalls keep happening)"
  angle: "Frame as the latest entry in a pattern first identified 10/09, using this trending, consumer-facing recall as the hook to re-explain how to check if your specific bottle is affected and why recalls have clustered this fall."
  why_now: "Real-time Google Trends breakout term with confirmed news driver (USA Today); 4+ other FDA recalls (baby sleep aid, pre-workout, supplement powder, smoked fish) have landed since the original recall-pattern piece ran 10/09."
  integrity_flags:
    - "⚠️ Integrity note: Primary FDA.gov recall notice not directly retrieved this session — confirmed via USA Today and MedShadow Foundation; verify lot numbers/NDC codes against FDA.gov before publishing."
  outline:
    intro: "What was recalled, by whom, and why it's trending now"
    sections:
      - "What Aurobindo Pharma's acetaminophen recall covers (lots, retailers, reason)"
      - "How to check if your bottle is affected"
      - "The broader 2026 recall pattern: 5 FDA actions since early October"
      - "What to do if you have an affected product"
    conclusion: "When to actually worry vs. routine FDA caution"
  key_data_points:
    - "Recall confirmed via Google Trends real-time breakout + USA Today coverage [URL unverified — pending FDA.gov retrieval]"
    - "5th+ major FDA consumer recall since Oct 7 (BP meds, eye drops, Gatorade, baby sleep aid, pre-workout, this one)"
  source_plan:
    - { publisher: "USA Today", url: "[URL unverified]", tier: 2, used_for: "Trend driver / breaking confirmation" }
    - { publisher: "MedShadow Foundation", url: "https://medshadow.org/drug-updates-recalls/fda-recalls-and-warnings/amazon-acetaminophen-millions-of-eye-drops-compounded-glutathione/", tier: 2, used_for: "Recall roundup context" }
    - { publisher: "FDA.gov Recalls Database", url: "https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts", tier: 1, used_for: "Primary verification — required before publish" }
  evidence_requirements: "Light — consumer safety explainer, not clinical claim; primary FDA notice still required for accuracy."
  expert_sources:
    - { type: "FDA spokesperson statement (published)", name: "Cite official FDA recall notice language directly", reason: "Tier-1 authority, avoids needing outreach" }
  internal_links: ["Prior recall-pattern piece (10/09)"]
  visual_brief: "Product packaging image + simple checklist graphic (lot number lookup)"
  seo:
    primary_keyword: "acetaminophen recall Amazon"
    supporting_keywords: ["Aurobindo Pharma recall", "FDA recall acetaminophen 2026", "is my Tylenol recalled"]
    format: "News explainer"
    schema_markup: "NewsArticle"
    cluster: "FDA & CDC regulatory updates"
  discover_notes: "Specific named entity + direct consumer Q&A fit ('is my product recalled') = strong AI-citation candidate once primary FDA source is linked."
  key_takeaways: ["Check lot numbers against FDA listing", "This is one of several recalls this fall, not an isolated event"]
  estimated_word_count: "700-900"
execution_notes: "Hold publish until FDA.gov notice is directly retrieved and linked."
confidence: medium
```

### P1 — West Nile Virus: North Carolina Fatalities

```yaml
brief:
  primary_headline: "West Nile Virus Has Killed Two People in North Carolina — What to Know as Cases Rise"
  alternate_headlines:
    - "North Carolina Reports West Nile Virus Deaths: Symptoms, Risk, and Prevention"
    - "Why West Nile Virus Cases Are Spiking This Fall"
  topic: "West Nile virus — North Carolina deaths"
  primary_entity: "West Nile virus (North Carolina outbreak)"
  search_intent: "informational (symptoms, risk) + evaluative (how worried should I be)"
  angle: "Use the breaking local fatality report as the hook for a national-scope explainer — most existing coverage is local/regional; opportunity for a broader symptoms/prevention/risk-factor piece citing CDC surveillance data."
  why_now: "Real-time Google Trends breakout, confirmed by WRAL reporting two deaths; distinct from the ongoing measles-outbreak story already covered twice this week — different pathogen, different public-health story."
  integrity_flags:
    - "⚠️ Integrity note: WRAL is currently the sole named source for the death count — corroborate against NC DHHS or CDC ArboNET surveillance data before publishing exact case/death numbers."
  outline:
    intro: "What happened in North Carolina"
    sections:
      - "What West Nile virus is and how it spreads"
      - "Symptoms and who's most at risk"
      - "Why cases cluster in late summer/early fall"
      - "Prevention: mosquito control, when to see a doctor"
    conclusion: "Current national case trend (CDC data)"
  key_data_points:
    - "Two deaths reported in North Carolina [WRAL, URL unverified]"
    - "CDC ArboNET national WNV case tracking — [to be added via CDC.gov]"
  source_plan:
    - { publisher: "WRAL", url: "[URL unverified]", tier: 2, used_for: "Breaking local confirmation" }
    - { publisher: "CDC — West Nile Virus", url: "https://www.cdc.gov/west-nile-virus/index.html", tier: 1, used_for: "Symptoms, national data, prevention guidance" }
  evidence_requirements: "Moderate — public health claim; CDC data required for national framing."
  expert_sources:
    - { type: "CDC/state epidemiologist (published guidance)", name: "Cite CDC West Nile virus guidance directly", reason: "Tier-1, no outreach needed" }
  internal_links: []
  visual_brief: "US map of WNV activity (CDC data) + mosquito prevention infographic"
  seo:
    primary_keyword: "West Nile virus symptoms"
    supporting_keywords: ["West Nile virus North Carolina", "West Nile virus deaths 2026", "West Nile virus prevention"]
    format: "News explainer"
    schema_markup: "NewsArticle"
    cluster: "Infectious disease / public health and epidemiology"
  discover_notes: "Strong AI-citation fit — specific, seasonal, maps to direct queries ('West Nile virus symptoms', 'is West Nile virus dangerous'); CDC primary source readily available."
  key_takeaways: ["Most infections are mild/asymptomatic but severe cases can be fatal", "Mosquito prevention is the primary defense"]
  estimated_word_count: "700-900"
execution_notes: "Corroborate death count with NC DHHS before publishing exact figures."
confidence: medium
```

### P2 — Retatrutide: Weight-Loss Trial Results

```yaml
brief:
  primary_headline: "Retatrutide: What the New 'Triple-Agonist' Weight-Loss Drug Trial Actually Found"
  alternate_headlines:
    - "Beyond Ozempic: Is Retatrutide the Next Weight-Loss Breakthrough?"
    - "Retatrutide Explained: How It Differs From Wegovy and Zepbound"
  topic: "Retatrutide clinical trial results"
  primary_entity: "Retatrutide"
  search_intent: "informational + comparative (vs. Ozempic/Zepbound)"
  angle: "Skeptical/clarifying — the 'stunning results' framing in aggregator coverage overstates certainty; brief should lead with actual trial design/data, then compare mechanism to existing GLP-1 drugs covered 10/11."
  why_now: "Real-time Google Trends breakout; weight-loss search category up +16 7-day delta; distinct drug from the Wegovy/Zepbound mechanism piece already published 10/11."
  integrity_flags:
    - "⚠️ Integrity note: Secondary coverage ('stunning results') overstates the finding — recommend leading with actual trial phase, sample size, and comparator drug data rather than aggregator framing."
  outline:
    intro: "What retatrutide is and why it's trending"
    sections:
      - "How retatrutide's triple-agonist mechanism differs from semaglutide/tirzepatide"
      - "What the trial actually measured (phase, duration, population)"
      - "Reported results vs. headline framing"
      - "Side effects and what's still unknown"
    conclusion: "Where retatrutide stands in the GLP-1 drug pipeline"
  key_data_points:
    - "Trial results reported via SciTechDaily [URL unverified — trace to underlying publication]"
    - "Comparison mechanism data from prior Wegovy/Zepbound brief (10/11)"
  source_plan:
    - { publisher: "SciTechDaily", url: "[URL unverified]", tier: 2, used_for: "Trend driver" }
    - { publisher: "Underlying peer-reviewed trial publication", url: "[pending — PubMed/NEJM lookup required]", tier: 1, used_for: "Primary data verification" }
  evidence_requirements: "Heavy — drug/treatment claim requires peer-reviewed primary source before publishing efficacy figures."
  expert_sources:
    - { type: "Endocrinologist or obesity medicine researcher (published commentary)", name: "Cite a named trial investigator from the primary publication", reason: "Required per health-sourcing rules — avoid presenting trial data without named researcher context" }
  internal_links: ["Wegovy/Zepbound mechanism brief (10/11)"]
  visual_brief: "Mechanism comparison chart: semaglutide vs. tirzepatide vs. retatrutide"
  seo:
    primary_keyword: "retatrutide weight loss"
    supporting_keywords: ["retatrutide vs Ozempic", "retatrutide clinical trial results", "triple agonist weight loss drug"]
    format: "News explainer + comparison table"
    schema_markup: "NewsArticle"
    cluster: "Chronic disease management / weight loss"
  discover_notes: "Good citation potential once tied to the primary trial publication; currently capped by secondary-only sourcing."
  key_takeaways: ["Retatrutide is not yet FDA-approved", "Early trial data is promising but preliminary — avoid overstating certainty"]
  estimated_word_count: "700-900"
execution_notes: "Must locate and cite the underlying peer-reviewed trial publication before publishing specific efficacy numbers."
confidence: medium
```

### P3 — Clinical Trial Diversity & the Women's Health Data Gap (Concise Brief)

```yaml
brief:
  headline: "Why Clinical Trials Still Underrepresent Women — and What's Being Done About It"
  topic: "Clinical trial diversity / women's health research gaps"
  angle: "Evaluative — two independent industry analyses (Clinical Trials Arena, Penn LDI) point to the same persistent gap; use as a news hook for an explainer on why trial diversity matters for drug safety/efficacy and what's changing (FDA/NIH diversity action plans)."
  key_data_points:
    - "Clinical Trials Arena: 'Women's health landscape shifting, but systemic hurdles remain'"
    - "Penn LDI: 'What Would It Take to Make Clinical Trials More Diverse?'"
  integrity_flags:
    - "⚠️ Integrity note: Ensure any statistics cited trace back to the original FDA/NIH diversity action plan rather than secondary paraphrase."
  expert_type_needed: "Clinical researcher or health policy researcher focused on trial diversity (cite named researcher from Penn LDI piece)"
  seo:
    primary_keyword: "clinical trial diversity women's health"
    format: "Evergreen explainer"
    serp_difficulty: "Medium"
  sources:
    - { publisher: "Clinical Trials Arena", url: "https://www.clinicaltrialsarena.com/features/womens-health-landscape-shifting-systemic-hurdles-remain-2/" }
    - { publisher: "Penn LDI", url: "https://ldi.upenn.edu/our-work/research-updates/what-would-it-take-to-make-clinical-trials-more-diverse/" }
  estimated_word_count: "500-650"
```

---

## 7. Rejected Topics Log

| Topic | Reason |
|---|---|
| Talarico mental health (trending term) | Brand safety — political figure, no evidence-based health angle |
| Mike Ditka / Mike Love health | Weak signal — celebrity health trending terms with no corroborating news story |
| WHO community mental health care | Existing — covered 10/10 |
| World Mental Health Day (EU Commission) | Existing — covered 10/07 & 10/10 |
| Late-night eating/liver follow-ons (Health.com, Medical Xpress) | Existing — covered 10/11 |
| Pew Research: wellness influencers | Existing — covered 10/07 |
| Lancet AMIE AI study | Existing — covered 10/09 |
| NYT AI chatbot urgent care trial | Existing — covered 10/09 |
| USC psilocybin trial | Existing — covered 10/11 |
| UC Davis AI medication device | Existing — covered 10/08 |
| ARPA-H Surpass program | Existing — covered 10/07 |
| Parkinson's microglia study | Existing — covered 10/08 |
| Gatorade / eye drops / BP medication recalls | Existing — covered 10/06–10/08 |
| KFF Health Tracking Poll (midterms) | Off-category — pure political healthcare opinion |
| NC treasurer / Atrium affordability | Off-category — local business/finance, not health science |
| NPR medical debt (LA hospitals) | Off-category — healthcare finance/policy, not core health science |
| NYT: Patty Murray op-ed | Off-category — pure political opinion |
| Virginia shellfish harvesting closure | Off-category — too narrow/local |
| Wellness-culture pieces (NYT polyester, "wellness darties," Harvard op-ed, campus fairs) | Off-category — lifestyle/cultural fluff, no evidence-based angle |
| Google Health/Fitbit product update | Off-category — consumer tech product news |
| Rutgers opioid-ban research impact | Rejected — niche policy angle, low general-audience relevance |
| UC Cincinnati NIH grant announcement | Rejected — funding announcement, no findings yet |
| XORTX gout drug (Canada) | Rejected — small biotech PR, low credibility, not patient-facing |
| Dell Medical School trial-standardization partnership | Rejected — too niche/process-oriented |
| Notre Dame positive-parenting/joy study | **Monitor (P5)** — single source, no corroboration, trend score below threshold; recheck in 7 days |
| UT Southwestern protein/intestinal-inflammation study | **Monitor (P5)** — single source, no corroboration, trend score below threshold; recheck in 7 days |

---

## 8. Integrity Flags — Consolidated

- ⚠️ **Amazon acetaminophen recall**: Primary FDA.gov notice not directly retrieved — confirmed via USA Today/MedShadow only. Verify before publishing lot numbers.
- ⚠️ **Retatrutide**: Secondary coverage overstates findings ("stunning results") — lead with actual trial data, not aggregator framing. Primary peer-reviewed publication still needs to be located.
- ⚠️ **West Nile virus NC**: Single named source (WRAL) for death count — corroborate with NC DHHS/CDC ArboNET before publishing exact figures.
- ⚠️ **Clinical trial diversity piece**: Confirm cited statistics trace to original FDA/NIH source documents, not secondary paraphrase.

---

## 9. Run Notes

- `site_url` not configured — self-check skipped throughout; competitor-list fallback used for duplicate/SERP-gap signals.
- Recurring-theme discipline applied: recall coverage, WHO/mental-health coverage, and AI-in-clinical-care coverage were all withheld from fresh "new" status unless a specific new development justified an `update` (only the recall cluster qualified).
- Two study-based candidates (Notre Dame, UTSW) were deliberately held at Skill 04 rather than advanced — single-source signals with no cross-channel corroboration do not meet the minimum trend-strength bar, consistent with the "skeptical assignment editor" default of no.
- Reddit and social-search collectors were unavailable this run; no candidate relied solely on social signal, so this did not affect retained picks.
- Dashboard not written to file in this session — HTML/CSV export deliverable pending confirmation of output destination.